Literature DB >> 12732408

The effects of escalating doses of smoked cocaine in humans.

Richard W Foltin1, Amie S Ward, Margaret Haney, Carl L Hart, Eric D Collins.   

Abstract

This study examined the effects of escalating doses of smoked cocaine in non-treatment-seeking cocaine users. Cocaine sessions were conducted twice per day for 3 consecutive days. During each session, one group of participants smoked a 12 mg cocaine dose, followed by a 25 mg dose, followed by four 50 mg doses at 14 min intervals (escalating-dose group); another group of participants smoked six 50 mg cocaine doses at 14 min intervals (fixed-dosing group). Cocaine produced dose-dependent increases in heart rate (HR), blood pressure, ratings of positive drug effect, e.g., "good drug effect", and ratings of cocaine dose, e.g., "liking", in the escalating-dose group. The 50 mg dose also increased these measures in the fixed-dosing group to a level that was not different than that observed following the initial 50 mg dose in the escalating-dose group. The largest effects of 50 mg cocaine were observed following the initial dose, with the latter 50 mg doses maintaining but not increasing these effects in both groups. The effects of cocaine in both groups were consistent for most measures within a day and between days. Resting baseline heart rate, blood pressure and cocaine craving were lower during the first session and higher thereafter. These results demonstrate that increasing the dose of cocaine during a bout, i.e., "binge", of cocaine use can increment the effects of cocaine, but administering the same cocaine dose maintains, but does not increment the effects of cocaine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12732408     DOI: 10.1016/s0376-8716(02)00343-5

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  26 in total

1.  Risperidone diminishes cocaine-induced craving.

Authors:  Richard De La Garza; Thomas F Newton; Ari D Kalechstein
Journal:  Psychopharmacology (Berl)       Date:  2004-09-25       Impact factor: 4.530

2.  Deficits in plasma oxytocin responses and increased negative affect, stress, and blood pressure in mothers with cocaine exposure during pregnancy.

Authors:  Kathleen C Light; Karen M Grewen; Janet A Amico; Maria Boccia; Kimberly A Brownley; Josephine M Johns
Journal:  Addict Behav       Date:  2004-11       Impact factor: 3.913

Review 3.  Rethinking cocaine-associated chest pain and acute coronary syndromes.

Authors:  Jonathan B Finkel; Gregary D Marhefka
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

Review 4.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

5.  Intranasal cocaine in humans: effects of sex and menstrual cycle.

Authors:  Stephanie L Collins; Suzette M Evans; Richard W Foltin; Margaret Haney
Journal:  Pharmacol Biochem Behav       Date:  2006-12-28       Impact factor: 3.533

6.  Using a novel alternative to drug choice in a human laboratory model of a cocaine binge: a game of chance.

Authors:  Suzanne K Vosburg; Margaret Haney; Eric Rubin; Richard W Foltin
Journal:  Drug Alcohol Depend       Date:  2010-03-25       Impact factor: 4.492

7.  A single-day paradigm of self-regulated human cocaine administration.

Authors:  D Matuskey; B Pittman; J I Chen; J Wanyiri; H Nadim; P Jatlow; R Gueorguieva; M N Potenza; P T Morgan; Z Bhagwagar; R T Malison
Journal:  Pharmacol Biochem Behav       Date:  2012-11       Impact factor: 3.533

8.  Presence and extent of coronary artery disease by cardiac computed tomography and risk for acute coronary syndrome in cocaine users among patients with chest pain.

Authors:  Fabian Bamberg; Christopher L Schlett; Quynh A Truong; Ian S Rogers; Wolfgang Koenig; John T Nagurney; Sujith Seneviratne; Sam J Lehman; Ricardo C Cury; Suhny Abbara; Javed Butler; Hang Lee; Thomas J Brady; Udo Hoffmann
Journal:  Am J Cardiol       Date:  2008-12-26       Impact factor: 2.778

Review 9.  Recommendations for Substance Abuse and Pain Control in Patients with Chronic Pain.

Authors:  Nalini Vadivelu; Alice M Kai; Gopal Kodumudi; Dan Haddad; Vijay Kodumudi; Niketh Kuruvilla; Alan David Kaye; Richard D Urman
Journal:  Curr Pain Headache Rep       Date:  2018-03-19

10.  Modafinil does not serve as a reinforcer in cocaine abusers.

Authors:  Suzanne K Vosburg; Carl L Hart; Margaret Haney; Eric Rubin; Richard W Foltin
Journal:  Drug Alcohol Depend       Date:  2009-09-23       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.